Cerevel Therapeutics Holdings Inc (CERE) stock is higher by 112.88% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives CERE stock a score of 72 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 92. CERE's rank also includes a long-term technical score of 83. The fundamental score for CERE is 40. In addition to the average rating from Wall Street analysts, CERE stock has a mean target price of $47.50. This means analysts expect the stock to climb 45.17% over the next 12 months. CERE has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on CERE!